EPCAM and breast carcinoma: Binding of the goat polyclonal R&D EpCAM antibody to the highest expressing feline oropharyngeal squamous cell carcinoma and human MCF-7 breast carcinoma cell lines was competitively inhibited by addition of recombinant human EpCAM.